Nicola C Hughes

发表

The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis.

Fabio Garofolo, Natasha Savoie, Steve Lowes, 2009, Bioanalysis.

2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis).

Sam H Haidar, Gustavo Mendes Lima Santos, Nicola C Hughes, 2018, Bioanalysis.

Assessing the matrix effects of hemolyzed samples in bioanalysis.

Nicola C Hughes, Navgeet Bajaj, Juan Fan, 2009, Bioanalysis.

Accurate mass measurement at enhanced mass-resolution on a triple quadrupole mass-spectrometer for the identification of a reaction impurity and collisionally-induced fragment ions of cabergoline.

Nicola C Hughes, A. Schoen, W. Winnik, 2003, Rapid communications in mass spectrometry : RCM.

High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities.

Nicola C Hughes, M. Splendore, M. Amad, 2003, Journal of mass spectrometry : JMS.

2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers).

Sam H Haidar, Olivier Le Blaye, Gustavo Mendes Lima Santos, 2017, Bioanalysis.

Recommendations on qPCR/ddPCR Assay Validation by GCC.

Nicola C Hughes, R. Guilbaud, M. Fjording, 2022, Bioanalysis.

Determination of carryover and contamination for mass spectrometry-based chromatographic assays

Nicola C Hughes, Navgeet Bajaj, Juan Fan, 2007, The AAPS Journal.

The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud.

Stephanie Cape, Roger Hayes, Jennifer Zimmer, 2017, Bioanalysis.

Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.

Stephanie Cape, Roger Hayes, Sumit Kar, 2019, Bioanalysis.

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 - hybrid LBA/LCMS and input from regulatory agencies).

Surinder Kaur, Jian Wang, Fabio Garofolo, 2015, Bioanalysis.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies).

Barry Jones, Jianing Zeng, An Song, 2016, Bioanalysis.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS).

Stephanie Cape, Scott Summerfield, Amanda Wilson, 2016, Bioanalysis.

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 - small molecules by LCMS).

Roger Hayes, Amanda Wilson, Eric Woolf, 2015, Bioanalysis.